📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Chemically modified, non-anticoagulant heparin derivatives are potent galectin-3 binding inhibitors and inhibit circulating galectin-3-promoted metastasis. (2015)

First Author: Duckworth CA

Attributed to: Shotgun functional glycomics of heparan sulphate saccharides: generating diverse libraries to decode biological selectivity funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.4409

PubMed Identifier: 26160844

Publication URI: http://europepmc.org/abstract/MED/26160844

Type: Journal Article/Review

Volume: 6

Parent Publication: Oncotarget

Issue: 27

ISSN: 1949-2553